How have ATNFW shares performed in 2024?

180 Life Sciences' stock was trading at $0.0042 at the beginning of 2024. Since then, ATNFW stock has increased by 114.3% and is now trading at $0.0090. View the best growth stocks for 2024 here .

Are investors shorting 180 Life Sciences?

180 Life Sciences saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 35,900 shares, an increase of 298.9% from the March 15th total of 9,000 shares. Based on an average daily volume of 48,100 shares, the short-interest ratio is presently 0.7 days. View 180 Life Sciences' Short Interest .

How do I buy shares of 180 Life Sciences?

Shares of ATNFW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ATNFW

180 Life Sciences (ATNFW) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ATNFW Stock Alerts

$0.0090

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.0090
▼
$0.0090
50-Day Range: $0.0058
▼
$0.0120
52-Week Range: $0.00
▼
$0.02

Volume: 129 shs
Average Volume: 49,140 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Social Media

Get 180 Life Sciences alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About 180 Life Sciences Stock (NASDAQ:ATNFW)

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

ATNFW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ATNFW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive ATNFW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:ATNFW
CUSIP: N/A
CIK: 1690080
Web: 180lifesciences.com
Phone: 650-507-0669
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Dr. Lawrence Steinman BA (Age 76)
M.D., Ph.D., Co-Founder & Executive Chairman
Comp: $168.75k
Dr. James N. Woody M.D. (Age 82)
Ph.D., CEO & Director
Comp: $617.77k
Mr. Ozan Pamir C.F.A. (Age 32)
CFO & Secretary
Comp: $410.24k
Dr. Jonathan B. Rothbard Ph.D. (Age 71)
Chief Scientific Officer
Comp: $260.34k
Prof. Jagdeep Nanchahal
Co-Founder & Chairman of Clinical Advisory Board
Mr. Jason Assad
Director of IR

Key Competitors

View All Competitors

ATNFW Stock Analysis - Frequently Asked Questions

How have ATNFW shares performed in 2024?: 180 Life Sciences' stock was trading at $0.0042 at the beginning of 2024. Since then, ATNFW stock has increased by 114.3% and is now trading at $0.0090.
View the best growth stocks for 2024 here.
Are investors shorting 180 Life Sciences?: 180 Life Sciences saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 35,900 shares, an increase of 298.9% from the March 15th total of 9,000 shares. Based on an average daily volume of 48,100 shares, the short-interest ratio is presently 0.7 days.
View 180 Life Sciences' Short Interest.
How do I buy shares of 180 Life Sciences?: Shares of ATNFW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATNFW) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial